Market News / Story
GenSight Biologics S.A. (SIGHT) Cash Falls To €0.7M; Runway Risk Flagged
·
GenSight Biologics S.A. reported €0.7M cash at Sept. 30, 2026, vs €1.7M at June 30, and warned of going-concern uncertainty. It estimates ~€16M net funding need and targets bridge financing of up to €2M by end-November to extend runway to late March 2027. Material Details #DetailAI Analyst View1Cash €0.7M at Sept 30 (vs €1.7M Jun 30)Severe liquidity; burn and minimal cash elevate near-term financing risk.2Material going-concern uncertaintySignals potential insolvency…